Literature DB >> 12574003

Postsystolic shortening of ischemic myocardium: a mechanism of abnormal intraventricular filling.

Stig Urheim1, Thor Edvardsen, Kjetil Steine, Helge Skulstad, Erik Lyseggen, Olaf Rodevand, Otto A Smiseth.   

Abstract

Acute myocardial ischemia has been associated with abnormal filling patterns in the left ventricular (LV) apex. We hypothesized that this may in part be due to postsystolic shortening of ischemic apical segments, which leads to reversal of early diastolic apical flow. Fourteen open-chest anesthetized dogs were instrumented with micromanometers in the LV apex and left atrium and myocardial sonomicrometers in the anterior apical LV wall. Intraventricular filling by color Doppler and wall motion by strain Doppler echocardiography (SDE) were assessed from an apical view. Measurements were taken before and after 5 min of left anterior descending coronary artery (LAD) occlusion. In four dogs, we measured the pressure difference between the LV apex and outflow tract. At baseline, peak early diastolic flow velocities in the distal one-third of the LV were directed toward apex (9.2 +/- 1.6 cm/s). After LAD occlusion, the velocities reversed (-2.3 +/- 0.4 cm/s, P < 0.01), indicating that blood was ejected from the apex toward the base during early filling. This interpretation was confirmed by wall motion analysis, which showed postsystolic shortening of apical myocardial segments. The postsystolic shortening represented 9.7 +/- 1.7% (P < 0.01) and 14.2 +/- 2.4% (P < 0.01) of end-diastolic segment length by SDE and sonomicrometry, respectively. Consistent with the velocity changes, we found reversal of the early diastolic pressure gradient from the LV apex to outflow tract. In the present model, acute LAD occlusion resulted in reversal of early diastolic apical flow, and this was attributed to postsystolic shortening of dyskinetic apical segments. The clinical diagnostic importance of this finding remains to be determined.

Entities:  

Mesh:

Year:  2003        PMID: 12574003     DOI: 10.1152/ajpheart.00320.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Post-systolic shortening: normal values and association with validated echocardiographic and invasive measures of cardiac function.

Authors:  Philip Brainin; Sofie Reumert Biering-Sørensen; Rasmus Møgelvang; Martina Chantal de Knegt; Flemming Javier Olsen; Søren Galatius; Gunnar Hilmar Gislason; Jan Skov Jensen; Tor Biering-Sørensen
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-19       Impact factor: 2.357

2.  Flow propagation velocity is not a simple index of diastolic function in early filling. A comparative study of early diastolic strain rate and strain rate propagation, flow and flow propagation in normal and reduced diastolic function.

Authors:  Asbjørn Støylen; Gunnar Skjelvan; Terje Skjaerpe
Journal:  Cardiovasc Ultrasound       Date:  2003-04-01       Impact factor: 2.062

Review 3.  Advanced echocardiographic techniques.

Authors:  Rebecca Perry; Majo Joseph
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

4.  Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: the multi-ethnic study of atherosclerosis.

Authors:  Bharath Ambale-Venkatesh; Anderson C Armstrong; Chia-Ying Liu; Sirisha Donekal; Kihei Yoneyama; Colin O Wu; Antoinette S Gomes; Gregory W Hundley; David A Bluemke; Joao A Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-10-20       Impact factor: 9.130

5.  Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.

Authors:  Åsmund T Røe; Marianne Ruud; Emil K Espe; Ornella Manfra; Stefano Longobardi; Jan M Aronsen; Einar Sjaastad Nordén; Trygve Husebye; Terje R S Kolstad; Alessandro Cataliotti; Geir Christensen; Ole M Sejersted; Steven A Niederer; Geir Øystein Andersen; Ivar Sjaastad; William E Louch
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.